Talyst to exhibit pharmacy automation and medication management products at HealthAchieve

Talyst, a market leader in pharmacy automation and medication management solutions will be exhibiting at the 2015 HealthAchieve Conference and Exhibition in Toronto, ON, November 2 - 4. The company will be showcasing its acute care pharmacy automation solutions as a part of the HIT Healthcare exhibition space.

Talyst will be displaying two pharmacy automation products at HealthAchieve, both new products for the Canadian market. InSite® 300 is the next generation oral solid packager designed and built to integrate easily with your pharmacy operations to provide fully automated unit-dose or multi-dose oral solid packaging. The InSite 300's patented canister design revolutionizes canister management and allows canister configuration within minutes in the pharmacy, drastically reducing pharmacy fill time.

Also on display will be AutoVault® Mini, an economical and space saving storage system providing controlled access and secure management of medications, including controlled substances. The modern and simple touchscreen interface streamlines workflow to safely manage your inventory and has extensive controlled substance reporting to help you meet regulatory requirements.

"We are excited to debut the InSite 300 and the AutoVault Mini to the Canadian market at HealthAchieve," said Scott Starke, General Manager of Talyst's Acute Care business unit. "After more than a decade of success in the U.S. market, HIT Healthcare is the perfect partner to assist us in bringing our products to hospital pharmacies across Canada," Starke added.

Talyst's AutoPharm® Enterprise, a powerful software platform that provides enterprise-wide medication management across your entire health system to offer greater inventory control, enhanced workflow efficiency, and improved patient safety will also be presented. The solution provides a complete view of purchasing, dispensing and productivity data ensuring inventory and drug shortages are more effectively managed.

SOURCE Talyst

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Hospital study shows adrenaline's rapid impact on cardiac arrest